InMed Shares Research in Peer-Reviewed Publication
InMed Pharmaceuticals shared the publication of a peer-reviewed article Drug Delivery and Translational Research showing pre-clinical study results from research...
Aequus and Ehave Announce Collaboration Agreement for Patient Data
Aequus Pharmaceuticals and Ehave announced a new collaboration agreement with each other on the basis of Aequus using Ehave's bioinformatics...
INSYS Begins Phase 3 CBD Trial
INSYS Therapeutics announced the start of its phase 3 clinical trial studying CBD oral solution treating infantile spasms rare type...
InMed Gets Conditional Approval for TSX Listing
InMed Pharmaceuticals announced it received conditional approval from the TSX to list its common shares in the exchange.
Schuyler County Opioid Lawsuit Fight Continues Forward
Schuyler County will hold a public hearing on March 12 to review a proposed local law declaring the opioid epidemic and its...
InMed Files Provisional Patent
InMed Pharmaceuticals announced the filing of a provisional patent application pertaining to the Company's proprietary biosynthesis program for the manufacture...
Revive Therapeutics Appoints Scientific Advisor for Cannabinoid-Based Therapeutics
Revive Therapeutics announced the appointment of Dr. Arun Sanyal as a scientific advisor for their cannabinoid-based therapeutics targeting liver diseases.
Corix Bioscience Signs Sales Agreement for Industrial Hemp
Corix Bioscience signed an agreement with Positively Green Organics for the resale of up to 22,000 pounds of industrial hemp...
Tetra Bio-Pharma Joins TSXV, Leaves CSE Behind
Tetra Bio-Pharma announced it has been approved to begin trading on the TSX Venture Exchange and has now applied to...
Nemus Bioscience To Present New Data on NB2111
NEMUS Bioscience announced the company will present new data of NB2111 analgesic and anti-addiction.